These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8251396)

  • 21. Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients.
    Katsarou O; Touloumi G; Antoniou A; Kouramba A; Hatzakis A; Karafoulidou A
    Haemophilia; 2005 Jul; 11(4):360-5. PubMed ID: 16011588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated plasma levels of 90K (Mac-2 BP) immunostimulatory glycoprotein in HIV-1-infected children.
    Gröschel B; Braner JJ; Funk M; Linde R; Doerr HW; Cinatl J; Iacobelli S
    J Clin Immunol; 2000 Mar; 20(2):117-22. PubMed ID: 10821463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. UK Haemophilia Centre Directors' Organisation.
    Darby SC; Ewart DW; Giangrande PL; Spooner RJ; Rizza CR
    Lancet; 1996 Jun; 347(9015):1573-9. PubMed ID: 8667864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AIDS and hemophilia: experience in the La Paz Hemophilia Center.
    Magallón Martínez M; Ortega F; Pinilla J
    Haemostasis; 1992; 22(5):281-92. PubMed ID: 1362177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Predictive significance of serum 90K/Mac-2BP on chemotherapy response in non-Hodgkin's lymphoma].
    Zhang DS; Jiang WQ; Li S; Zhang XS; Mao H; Chen XQ; Li YH; Zhan J; Wang FH
    Ai Zheng; 2003 Aug; 22(8):870-3. PubMed ID: 12917038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticardiolipin antibodies are elevated in HIV-1 infected haemophiliacs but do not predict for disease progression.
    Panzer S; Stain C; Hartl H; Dudczak R; Lechner K
    Thromb Haemost; 1989 Feb; 61(1):81-5. PubMed ID: 2526388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of AIDS and excess of mortality associated with HIV in haemophiliacs in the United Kingdom: report on behalf of the directors of haemophilia centres in the United Kingdom.
    Darby SC; Rizza CR; Doll R; Spooner RJ; Stratton IM; Thakrar B
    BMJ; 1989 Apr; 298(6680):1064-8. PubMed ID: 2497891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble IL-2 receptor and tumour necrosis factor-alpha in plasma of haemophilia patients infected with HIV.
    Noronha IL; Daniel V; Schimpf K; Opelz G
    Clin Exp Immunol; 1992 Feb; 87(2):287-92. PubMed ID: 1735193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of a monoclonal-antibody-defined antigen (90K) in the sera of patients with ovarian cancer.
    Scambia G; Panici PB; Baiocchi G; Perrone L; Iacobelli S; Mancuso S
    Anticancer Res; 1988; 8(4):761-4. PubMed ID: 3178164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating Galectin-1 and 90K/Mac-2BP Correlated with the Tumor Stages of Patients with Colorectal Cancer.
    Wu KL; Chen HH; Pen CT; Yeh WL; Huang EY; Hsiao CC; Yang KD
    Biomed Res Int; 2015; 2015():306964. PubMed ID: 26448934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study.
    O'Brien TR; Blattner WA; Waters D; Eyster E; Hilgartner MW; Cohen AR; Luban N; Hatzakis A; Aledort LM; Rosenberg PS; Miley WJ; Kroner BL; Goedert JJ
    JAMA; 1996 Jul; 276(2):105-10. PubMed ID: 8656501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA antigens as predictors of disease progression in HIV-infected haemophilia patients (a 22 years' follow up).
    Papasteriades CH; Economidou J; Pappas H; Kapsimali V; Psarra K; Katsarou O; Karafoulidou A; Mandalaki T
    Haemophilia; 2005 Jul; 11(4):371-5. PubMed ID: 16011590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unusually high level of a tumor-associated antigen in the serum of human immunodeficiency virus-seropositive individuals.
    Natoli C; Iacobelli S; Ghinelli F
    J Infect Dis; 1991 Sep; 164(3):616-7. PubMed ID: 1869854
    [No Abstract]   [Full Text] [Related]  

  • 34. The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K Is Species Specific.
    Lodermeyer V; Ssebyatika G; Passos V; Ponnurangam A; Malassa A; Ewald E; Stürzel CM; Kirchhoff F; Rotger M; Falk CS; Telenti A; Krey T; Goffinet C
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatic juice 90K and serum CA 19-9 combined determination can discriminate between pancreatic cancer and chronic pancreatitis.
    Gentiloni N; Caradonna P; Costamagna G; D'Ostilio N; Perri V; Mutignani M; Febbraro S; Tinari N; Iacobelli S; Natoli C
    Am J Gastroenterol; 1995 Jul; 90(7):1069-72. PubMed ID: 7611198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
    Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J
    BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment.
    Lee CA; Phillips AN; Elford J; Janossy G; Griffiths P; Kernoff P
    BMJ; 1991 Nov; 303(6810):1093-6. PubMed ID: 1781870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal analysis of the 90K glycoprotein in the Italian HIV-seroconversion study: temporal trend and predictability of the maturity of HIV infection.
    Dorrucci M; Iacobelli S; Suligoi B; Pezzotti P; Sinicco A; Angarano G; Tinari N; Rezza G
    J Biol Regul Homeost Agents; 2004; 18(1):18-25. PubMed ID: 15323356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variations in serum IL-7 and 90K/Mac-2 binding protein (Mac-2 BP) levels analysed in cohorts of HIV-1 patients and correlated with clinical changes following antiretroviral therapy.
    Darcissac EC; Vidal V; De La Tribonniere X; Mouton Y; Bahr GM
    Clin Exp Immunol; 2001 Nov; 126(2):287-94. PubMed ID: 11703373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of a novel interferon-inducible 90K tumor antigen.
    D'Ostilio N; Natoli C; Grassadonia A; Rossi N; Di Stefano P; Amatetti C; Tinari N; Iacobelli S
    Ann N Y Acad Sci; 1996 Apr; 784():288-93. PubMed ID: 8651577
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.